Principal Scientist AstraZeneca Pharmaceuticals Waltham, Massachusetts
Join Wenzhan Yang and several authors in Poster Forum #4 in the Solution Center (Exhibit Halls 3 & 4) for a conversation about posters on the topic, “Innovative Formulation and Analytical Strategies to Enhance the Performance, Stability, and Predictability of Amorphous Solid Dispersions (ASDs) for Poorly Water-Soluble Drugs.”, that she is especially excited about.
T0930-09-57 Dissolution-Membrane Permeation Combined with Dissolution Imaging for Bioperformance Prediction of Amorphous Solid Dispersion Manufactured by a Novel Co-Precipitation Process, Corinne B. Jankovsky, Ph.D., Boehringer Ingelheim
T1030-09-59 Spray-Dried Amorphous Solid Dispersions of Celecoxib-PVPVA64-SBEβCD Ternary Complexes: Preparation, Flory Huggins Interaction Parameters and Dissolution Enhancements, Indeewara Munasinghe, MS, University of Kansas
W0930-09-56 Assessing the Performance of Lipids as Surfactants to Enhance the Release Profile of a Model BCS Class IV Compound from Amorphous Solid Dispersions (ASDs), Masumi Dave, Ph.D., Gattefosse Corporation
M1330-07-45 Formulation of Rapidly Dissolving Amorphous Solid Dispersion of Posaconazole, an Extremely Water-Insoluble Basic Drug via Hot-Melt Extrusion by Applying Acid-Base Supersolubilization Principle, Mufaddal Hasan Kathawala, Ph.D., St. John’s University
M1130-08-52 Development of Organic Solvent-Free Amorphous Solid Dispersions of Felodipine with PEGs via Supercritical CO₂ Processing: A Green Strategy for Enhanced Dissolution and ODT Formulation, Siva Satyanarayana Kolipaka, Ph.D., University of Greenwich
